文献速递创伤与烧伤重症综合管理与镇静镇痛

腹膜前盆腔填塞是否增加创伤患者静脉血栓栓塞风险?一项覆盖17家一级创伤中心的前瞻性多中心分析

Does preperitoneal packing increase venous thromboembolim risk among trauma patients? A prospective multicenter analysis across 17 level I trauma centers.
PubMed 文献 · J Trauma Acute Care Surg · 2024-07-26
一句话结论在17家一级创伤中心1,387例骨盆骨折患者中,腹膜前盆腔填塞、盆腔动脉栓塞与骨盆切开复位内固定均非静脉血栓栓塞的独立危险因素;入院24小时内启动药物预防可使静脉血栓栓塞发生率减半(HR 0.55)。

该研究基于17家美国一级创伤中心组成的CLOTT研究组观察性数据,纳入年龄18至40岁且至少有一项独立静脉血栓栓塞危险因素的骨盆骨折患者1,387例,比较腹膜前盆腔填塞、盆腔动脉栓塞与骨盆切开复位内固定相对于未行盆腔干预者的静脉血栓栓塞风险,主要结局为静脉血栓栓塞,采用竞争风险分析。结果显示总体静脉血栓栓塞发生率为5.6%,骨盆切开复位内固定组最高(24.7%),腹膜前盆腔填塞组9.0%,盆腔动脉栓塞组2.6%;多因素竞争风险分析后,三种盆腔干预均与静脉血栓栓塞无显著相关。入院24小时内启动静脉血栓栓塞药物预防可独立使静脉血栓栓塞发生率减半(HR 0.55;CI 0.33-0.91)。作者认为骨盆骨折干预似乎不是静脉血栓栓塞的独立危险因素,而早期药物预防对这一高危人群仍然关键。

要点

  • 1,387例骨盆骨折患者总体静脉血栓栓塞发生率为5.6%,骨盆切开复位内固定组24.7%、腹膜前盆腔填塞组9.0%、盆腔动脉栓塞组2.6%。
  • 多因素竞争风险分析后,腹膜前盆腔填塞、盆腔动脉栓塞与骨盆切开复位内固定均与静脉血栓栓塞无显著相关。
  • 入院24小时内启动静脉血栓栓塞药物预防可独立使静脉血栓栓塞发生率减半(HR 0.55;CI 0.33-0.91)。
  • 作者认为骨盆骨折干预似乎不是静脉血栓栓塞的独立危险因素,入院24小时内启动药物预防对这一高危人群仍关键。

适用人群与场景

  • 年龄18至40岁、至少有一项独立静脉血栓栓塞危险因素的骨盆骨折患者,数据来自17家美国一级创伤中心组成的CLOTT研究组。

诊断标准与关键阈值

  • CLOTT研究纳入标准:年龄18至40岁,且至少有一项独立静脉血栓栓塞危险因素。
  • 主要结局为静脉血栓栓塞,包括深静脉血栓、肺栓塞或肺血栓。

处置流程与药物剂量

  • 入院24小时内启动静脉血栓栓塞药物预防可独立使静脉血栓栓塞发生率减半(HR 0.55;CI 0.33-0.91)。

研究设计与关键结果

  • 研究类型为基于17家一级创伤中心CLOTT研究组的观察性多中心分析,纳入1,387例骨盆骨折患者,比较腹膜前盆腔填塞、盆腔动脉栓塞与骨盆切开复位内固定相对于未行盆腔干预者的静脉血栓栓塞风险,采用竞争风险分析。
  • 总体静脉血栓栓塞发生率为5.6%;骨盆切开复位内固定组最易发生静脉血栓栓塞(24.7%),腹膜前盆腔填塞组为9.0%,盆腔动脉栓塞组为2.6%。
  • 多因素竞争风险分析后,三种骨盆骨折治疗干预(腹膜前盆腔填塞、盆腔动脉栓塞、骨盆切开复位内固定)均与静脉血栓栓塞无显著相关。
  • 入院24小时内启动静脉血栓栓塞药物预防可独立使静脉血栓栓塞发生率减半(HR 0.55;CI 0.33-0.91)。

证据类型、等级与局限

  • 证据类型:观察性多中心分析(CLOTT研究组数据);证据等级:治疗性研究,Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为骨盆骨折干预(腹膜前盆腔填塞、盆腔动脉栓塞、骨盆切开复位内固定)似乎不是静脉血栓栓塞的独立危险因素。
  • 作者认为入院24小时内启动静脉血栓栓塞药物预防对这一高危人群仍关键,可显著减少静脉血栓栓塞形成。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Pelvic fractures are associated with a high risk of venous thromboembolism (VTE). Among treatment options, including pelvic angioembolization (PA), preperitoneal pelvic packing (PPP), and pelvic open reduction internal fixation (ORIF), PPP has been postulated as a VTE risk factor. We aimed to characterize the risk of VTE among pelvic fracture patients receiving PPP, PA or ORIF.

METHODS: We used observational data from a 17-site Consortium of Leaders in the Study of Traumatic Thromboembolism (CLOTT) study group, a US level I trauma center collaborative working to identify factors associated with posttraumatic VTE, deep venous thrombosis, pulmonary embolism, or pulmonary thrombosis. The CLOTT criteria included age 18 to 40 years with at least one independent VTE risk factor. We compared outcomes of PPP, PA, and pelvic ORIF to reference of no pelvic intervention. Our primary outcome was VTE. A competing risk analysis was performed.

RESULTS: Among 1,387 pelvic fracture patients, VTE incidence was 5.6%. The ORIF patients were most likely to develop VTE (24.7%), while VTE incidence for PPP was 9.0% and 2.6% for PA. After multivariate, risk-competing analysis, none of the three treatment interventions for pelvic fractures were significantly associated with VTE. Initiation of VTE prophylaxis in the first 24 hours of admission independently halved VTE incidence (hazard ratio, 0.55; confidence interval, 0.33-0.91).

CONCLUSION: Pelvic fracture interventions do not appear to be independent risk factors for VTE in our study. Initiation of VTE pharmacoprophylaxis within the first 24 hours of admission remains critical to significantly decreasing VTE formation in this high-risk population.

LEVEL OF EVIDENCE: Therapeutic Study; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Knowlton LM, Sauaia A, Moore EE, et al. Does preperitoneal packing increase venous thromboembolim risk among trauma patients? A prospective multicenter analysis across 17 level I trauma centers. J Trauma Acute Care Surg. 2024. PMID: 39058389. doi:10.1097/TA.0000000000004416

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。